2027 Cherry Blossom Allergy Conference (CBAC)

Washington, DC US
March 19, 2027 to March 21, 2027

image

We are excited to welcome you to the 3rd Annual Cherry Blossom Allergy Conference that will take place March 19-21, 2027. The conference will return to the beautiful InterContinental The Wharf in Washington D.C. This 3-day CME program – developed by the American College of Allergy, Asthma & Immunology (ACAAI), along with Dr. Rachel Schreiber and Dr. Kristin Sokol – will highlight new insights into the diagnosis, evaluation and treatment of various allergic and immunologic conditions, with an attention to real-world clinical application.

Sessions are designed to be engaging, interactive, and fun. Panel discussions will take place, highlighting the most up-to-date evidence and therapeutics for the diseases we see daily. Attendees will hear from experts not only in the specialty of allergy/immunology, but also from experts in the fields of pulmonology and dermatology, who will offer insights and perspectives regarding new paradigms of care.

In addition, this will be a family affair! Plan to bring your family to the nation’s capital at the most gorgeous time of the year – cherry blossom season. We will have a welcome dinner on Friday night, and our Saturday and Sunday sessions will be scheduled to allow for family time in the afternoons. A free shuttle from the Intercontinental Wharf at the waterfront will transport you to some of the top attractions in DC, including the National Mall (near the Smithsonian Air and Space Museum and the Smithsonian National Museum of Natural History), L’Enfant Plaza (near the Spy Museum), and the Duck Pond.

Make plans now to join us in DC during cherry blossom season!

REGISTRATION FEE
$275/attendee
Free for students, residents and FITs (College membership is free for students, residents and Fellows-in-Training)

GUEST FEE
$50/guest to attend Friday's Welcome Dinner (children 0-12 years old FREE)
Please include first and last name of guest(s) in the Order Comments during checkout.
If adding children ages 13-18, please include ages.

VENUE INFORMATION
Please see the Venue tab for hotel details.
The deadline for hotel reservations is February 26, 2027.

CONFERENCE REFUNDS/CANCELLATIONS
Refunds, cancellations, and changes are available (minus $75 administration fee) if your request is received via email ([email protected]) on or before March 5, 2027. 
Cancellation requests received after March 5, 2027 are not eligible for a refund.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunology and the Cherry Blossom Allergy Conference (CBAC). The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 8.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 8.5 contact hours.

Commercial Support
TBD

Target Audience

Practicing allergists
Allied health professionals

Learning Objectives

At the conclusion of this activity, attendees should be able to:

1. Recognize common dermatologic conditions encountered in allergy practice and identify key features that guide diagnosis and management.
2. Evaluate common causes of acute and chronic pruritus and apply appropriate diagnostic and treatment strategies.
3. Describe the immunologic mechanisms underlying food oral immunotherapy and their relationship to treatment outcomes.
4. Evaluate available food allergy treatment options and develop individualized management plans based on patient characteristics and treatment goals.
5. Apply evidence-based strategies to manage complex patients, treatment reactions, and challenging scenarios involving environmental and venom immunotherapy.
6. Recognize clinical features suggestive of inborn errors of immunity and identify appropriate initialdiagnostic evaluations.
7. Apply current recommendations for anaphylaxis recognition and management, including appropriate use of available epinephrine delivery options.
8. Differentiate mast cell disorders and other causes of elevated serum tryptase using established diagnostic criteria and appropriate evaluation strategies.
9. Apply current asthma guidelines to guide treatment decisions and select appropriate biologic therapy for patients with severe asthma.
10. Individualize biologic selection in various allergic and immunologic disorders by integrating disease phenotype, biomarkers, comorbidities, prior treatment response, and patient preferences.

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
  
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships with ineligible companies have been mitigated.

Course summary

Available credit: 
  • 8.50 AMA PRA Category 1 Credit™
  • 8.50 Attendance
  • 8.50 CBRN
Course opens: 
10/14/2026
Course expires: 
12/31/2027
Event starts: 
03/19/2027 - 6:30pm CDT
Event ends: 
03/21/2027 - 12:00pm CDT
Cost:
$275.00
Add to calendar: 
Rating: 
0

Cherry Blossom Allergy Conference Agenda 
InterContinental Wharf D.C. 
March 19-21, 2027

Education sessions held in Waterside Ballroom I and II

Friday, March 19

6:30 pm - Welcome Dinner @ Intercontinental Wharf D.C.
Reception and Dinner
Waterside Ballroom I and II, 2nd Floor 

Saturday, March 20 

7:00-7:30 am - Visit Exhibitors/Morning Coffee and Tea

7:30-8:10 am - Complimentary Breakfast 
Non-CME Sponsored Product Theater Presentation
Waterside III 2nd Floor 

8:15-8:20 am - Welcome Remarks 
Rachel Schreiber, MD & Kristin Sokol, MD

8:20- 9:00 am Moderator: TBD
What Is That Rash? A Visual Guide for the Practicing Allergist, Ben Lockshin, MD
9:00 am- 9:05 am Q&A 

9:05-10:00 am Moderator: TBD
Panel Discussion: Itch Across the Allergy–Dermatology Spectrum: A Case-Based Expert Panel, Ben Lockshin MD, Jay Lieberman, MD and Saurabh Singh, MD

10:00-10:45am - Visit Exhibitors/ Morning Refreshment Break
Seaport Room 

10:45-11:25 am Moderator: TBD
Immune Mechanisms of Food Oral Immunotherapy, Carla Davis, MD
11:25-11:30 am Q&A

11:30 am-12:10 pm Moderator: TBD 
Food allergy Treatment in Clinical Practice: From Patient Selection to Long-Term Success, Shahzad Mustafa, MD
Q&A: 12:10 pm – 12:15 pm 

12:15-1:15 pm Moderator: Andrej Petrov, MD 
Panel Discussion: Environmental and Venom Immunotherapy in the Real World: Difficult Patients, Difficult Reactions, and Nontraditional Protocols, David Golden MD, Scott Commins MD, and Shahzad Mustafa, MD

1:15-2:00 pm - Complimentary Lunch 
Non-CME Product Theater Presentation 
Waterside III

Afternoon on own 

Sunday, March 21 
7:00-7:30 am - Visit Exhibitors/Morning Coffee and Tea

7:30-8:10 am - Complimentary Breakfast 
Non-CME Product Theater Presentation
Waterside III 2nd Floor 

8:15-8:20 am - Welcome Remarks 
Rachel Schreiber, MD & Kristin Sokol, MD

8:20-9:00 am Moderator: TBD
Primary Immunodeficiency in Everyday Allergy Practice, Antoine Azar, MD 
9:00-9:05 am Q&A 

9:05-10:00 am Moderator: TBD
Panel Discussion: Anaphylaxis in 2027: Recognition, Management, and the Changing Epinephrine Landscape, David Golden, MD, Jay Lieberman, MD, and Scott Commins, MD

10:00-10:45am - Visit Exhibitors/ Morning Refreshment Break
Seaport Room

10:45-11:25 am Moderator: TBD
MCAS, Mastocytosis, and Elevated Tryptase: Sorting out the Mast Cell Maze, Jay Lieberman, MD 
11:25-11:30 am Q&A

11:30 am-12:10 pm Moderator: TBD 
Asthma in 2027: From Guidelines to Biologic Selection, John Oppenheimer, MD
Q&A: 12:10-12:15 pm 

12:15-1:15 pm Moderator: Andrej Petrov, MD
Panel Discussion: One Patient, Five Biologics: How the Experts Choose, Shahzad Mustafa MD, John Oppenheimer MD, and Antoine Azar MD

1:15-2:00 pm - Complimentary Lunch 
Non-CME Product Theater Presentation
Waterside III

Afternoon on own  
 

InterContinental Washington DC - The Wharf
801 Wharf St SW
Washington, DC 20024
United States

Hotel Room Rate & Resort Fee: $409 Single / Double + tax (NOTE: You may see the amenity fee charged as you reserve the room, but it will NOT be charged at check out.)
Hotel cancellation policy: Free cancellation until 6:00 PM local hotel time on Wed 17 Mar 2027. 

To make reservations online, please click here

To make reservations by phone, please call: 202-878-8586

For questions about Room Reservations, please contact:
Reservations Team: [email protected]
Shengyl Poshka, Group Reservations Coordinator: [email protected]

The deadline for hotel reservations is February 26, 2027.
image

The Intercontinental at The Wharf DC is perfectly placed on the beautiful Potomac River. The Wharf enjoys the most incredible waterfront views of D.C. Steps away from America’s political epicenter, the hotel embraces guests with an exquisitely curated resort destination that reignites the river’s edge. The Wharf has immediate access to major roadways, is blocks away from public transit stops, and a short five miles away from the Reagan National Airport. The Wharf has free neighborhood shuttle service, and they have a roundtrip shuttle route to the National Mall. Each room at the InterContinental includes a Nespresso machine, a hot water kettle, an executive Desk with ample space for working, a refreshment bar and an in-room safe. In addition, there is a complimentary morning newspaper, complimentary overnight shoeshine and 24-hour in-room dining.

Check back for updates and disclosures

All relevant financial relationships with ineligible companies have been mitigated. 

Kristin Sokol, MD Planner
Advisor: Aquestive, DBV, Genentech, Kaleo
Consultant: Aquestive, Genentech
Speaker: Novartis, DBV

Antoine Azar, MD Speaker
Scott Commins, MD, Panelist
Carla Davis, MD Speaker 
David Golden, MD Panelist
Jay Lieberman, MD Speaker
Benjamin Lockshin, MD Speaker 
Shahzad Mustafa, MD Speaker
John Oppenheimer, MD Speaker 
Andrej Petrov, MD Panelist
Saurabh Singh, MD, Panelist

The following have no relevant financial relationships with ineligible companies:

Rachel Schreiber, MD Planner

Available Credit

  • 8.50 AMA PRA Category 1 Credit™
  • 8.50 Attendance
  • 8.50 CBRN

Price

Cost:
$275.00
Please login or create an account to take this course.

Guests are welcome to attend Friday's Welcome Dinner!
Add a dinner guest to your registration, $50 per guest (children 0-12 years old FREE)
Please include first and last name of guest(s) in the Order Comments during checkout.
If adding children ages 13-18, please include ages.